Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care

1. Department of Health. Obesity general information. 1 February 2011. Available: http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publichealth/Obesity/DH_078098. Accessed 8 May 2015.

2. World Health Organization. Obesity and overweight. Fact sheet no. 311. January 2015. Available: http://www.who.int/mediacentre/factsheets/fs311/en/index.html. Accessed 8 May 2015.

3. National Institute for Health and Care Excellence. Obesity prevention. NICE guidelines CG43. December 2006. Available: http://guidance.nice.org.uk/CG43. Accessed 8 May 2015.

4. National Health Service Commissioning Board. Clinical commissioning policy: complex and specialised obesity surgery. April 2013. NHSCB/A05/P/a. Available: https://www.england.nhs.uk/wp-content/uploads/2013/04/a05-p-a.pdf. Accessed 20 November 2015.

5. National Heart, Lung, and Blood Institute Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Report No. 98–4083. Bethesda (Maryland): National Heart, Lung, and Blood Institute; 1998.

6. National Institute for Health and Care Excellence. Obesity: identification, assessment and management. NICE guidelines CG189. November 2014. Available: http://www.nice.org.uk/guidance/cg189. Accessed 15 May 2015.

7. Courcoulas AP, Goodpaster BH, Eagleton JK, Belle SH, Kalarchian MA, Lang W, et al. Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg. 2014;149:707–715. doi: 10.1001/jamasurg.2014.467 24899268

8. O’Brien PE, Brennan L, Laurie C, Brown W. Intensive medical weight loss or laparoscopic adjustable gastric banding in the treatment of mild to moderate obesity: long-term follow-up of a prospective randomised trial. Obes Surg. 2013 23:1345–1353. doi: 10.1007/s11695-013-0990-3 23760764

9. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–1576. doi: 10.1056/NEJMoa1200225 22449319

10. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577–1585. doi: 10.1056/NEJMoa1200111 22449317

11. Campbell J, Dedman DJ, Eaton SC, Gallagher AM, Williams TJ. Is the CPRD GOLD population comparable to the U.K. population? Pharmacoepidemiol Drug Saf 2013;22(Suppl 1):280.

12. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol. 2010;69:4–14. doi: 10.1111/j.1365-2125.2009.03537.x 20078607

13. Bhaskaran K, Forbes H, Douglas I, Leon D, Smeeth L. Representativeness and optimal use of body mass index (BMI) in the UK Clinical Practice Research Datalink (CPRD). BMJ Open 2013;3:e003389. doi: 10.1136/bmjopen-2013-003389 24038008

14. Lewis JD, Bilker WB, Weinstein RB, Strom BL. The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf. 2005;14:443–451. doi: 10.1002/pds.1115 15898131

15. Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28:3083–3107. doi: 10.1002/sim.3697 19757444

16. Stürmer T, Rothman KJ, Avorn J, Glynn RJ. Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution—a simulation study. Am J Epidemiol. 2010;172:843–854. doi: 10.1093/aje/kwq198 20716704

17. Arterburn DE, Olsen MK, Smith V Livingston EH, Van Scoyoc L, Yancy WS Jr, et al. Association between bariatric surgery and long-term survival. JAMA. 2015;313:62–70. doi: 10.1001/jama.2014.16968 25562267

18. Health and Social Care Information Centre. Health Survey for England 2013: health, social care and lifestyles. Summary of key findings. Available: http://www.hscic.gov.uk/catalogue/PUB16076/HSE2013-Sum-bklet.pdf. Accessed 20 May 2015.

19. Still CD, Wood GC, Chu X, Manney C, Strodel W, Petrick A, et al. Clinical factors associated with weight loss outcomes after Roux-en-Y gastric bypass surgery. Obesity. 2014;22:888–894. doi: 10.1002/oby.20529 23804287

20. Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro NN. Bariatric surgery worldwide 2013. Obes Surg. 2015;25:1822–1832. doi: 10.1007/s11695-015-1657-z 25835983

21. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311:806–814. doi: 10.1001/jama.2014.732 24570244

22. Wellbourn R, Small P, Finlay I, Sareela A, Somers S, Mahawar K, et al. The United Kingdom National Bariatric Surgery Registry: second registry report. London: British Obesity & Metabolic Surgery Society; 2014.

23. Canadian Agency for Drugs and Technologies in Health. Bariatric surgical procedures for obese and morbidly obese patients: a review of comparative clinical and cost-effectiveness, and guidelines. 24 April 2014. Ottawa: Canadian Agency for Drugs and Technologies in Health. Available: http://www.ncbi.nlm.nih.gov/books/PMH0071568/. Accessed 20 November 2015.

24. Zhang Y, Wang J, Sun X, Cao Z, Xu X, Liu D, et al. Laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass for morbid obesity and related comorbidities: a meta-analysis of 21 studies. Obes Surg. 2015;25:19–26. doi: 10.1007/s11695-014-1385-9 25092167

25. Peterli R, Borbély Y, Kern B, Gass M, Peters T, Thurnheer M, et al. Early results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg. 2013;258:690–694. doi: 10.1097/SLA.0b013e3182a67426 23989054

26. Young MT, Gebhart A, Phelan MJ, Nguyen NT. Use and outcomes of laparoscopic sleeve gastrectomy vs laparoscopic gastric bypass: analysis of the American College of Surgeons NSQIP. J Am Coll Surg. 2015;220:880–885. doi: 10.1016/j.jamcollsurg.2015.01.059 25907869

27. Manning S, Carter NC, Pucci A, Jones A, Elkalaawy M, Cheung WH, et al. Age- and sex-specific effects on weight loss outcomes in a comparison of sleeve gastrectomy and Roux-en-Y gastric bypass: a retrospective cohort study. BMC Obes. 2014;1:12. doi: 10.1186/2052-9538-1-12 26217504

28. Goitein D, Raziel A, Szold A, Sakran N. Assessment of perioperative complications following primary bariatric surgery according to the Clavien-Dindo classification: comparison of sleeve gastrectomy and Roux-Y gastric bypass. Surg Endosc. 2015 Apr 11. E-pub ahead of print. doi: 10.1007/s00464-015-4205-y

29. Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934. doi: 10.1136/bmj.f5934 24149519

30. Sugerman HJ, Starkey JV, Birkenhauer R. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg 1987;205:613–624. 3296971

31. Søvik TT, Taha O, Aasheim ET, Engström M, Kristinsson J, Björkman S, et al. Randomized clinical trial of laparoscopic gastric bypass versus laparoscopic duodenal switch for superobesity. Br J Surg. 2010;97:160–166. doi: 10.1002/bjs.6802 20035530

32. Himpens J, Dapri G, Cadiere GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg. 2006;16:1450–1456. 17132410

33. Dixon JB, O’Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316–323. doi: 10.1001/jama.299.3.316 18212316

34. Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13:1–190,215–357,iii–iv. doi: 10.3310/hta13410

35. Lee WJ, Chong K, Ser KH, Lee YC, Chen SC, Chen JC, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146:143–148. doi: 10.1001/archsurg.2010.326 21339423

36. Kehagias I, Karamanakos SN, Argentou M, Kalfarentzos F. Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the management of patients with BMI < 50 kg/m2. Obes Surg. 2011;21:1650–1656. doi: 10.1007/s11695-011-0479-x 21818647

37. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 2008;247:401–407. doi: 10.1097/SLA.0b013e318156f012 18376181

38. Courcoulas AP, Christian NJ, Belle SH, Berk PD, Flum DR, Garcia L, et al. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA. 2013;10:2416–2425. doi: 10.1001/jama.2013.280928

39. Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273:219–234. doi: 10.1111/joim.12012 23163728

40. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, et al. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370:2002–2013. doi: 10.1056/NEJMoa1401329 24679060

41. Wentworth JM, Playfair J, Laurie C, Ritchie ME, Brown WA, Burton P, et al. Multidisciplinary diabetes care with and without bariatric surgery in overweight people: a randomised controlled trial, Lancet Diabetes Endocrinol. 2014;2:545–552. doi: 10.1016/S2213-8587(14)70066-X 24731535

42. Svane MS, Madsbad S. Bariatric surgery—effects on obesity and related co-morbidities. Curr Diabetes Rev. 2014:10:208–214. 24934290

43. Sjöström L, Peltonen M, Jacobson P, Sjöström CD, Karason K, Wedel H, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307:56–65. doi: 10.1001/jama.2011.1914 22215166

44. Booth H, Khan O, Prevost T, Reddy M, Dregan A, Charlton J, et al. Incidence of type 2 diabetes after bariatric surgery: population-based matched cohort study. Lancet Diabetes Endocrinol. 2014;2:963–968. doi: 10.1016/S2213-8587(14)70214-1 25466723

45. Sjöström L, Gummesson A, Sjöström CD, Narbro K, Peltonen M, Wedel H, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 2009;10:653–662. doi: 10.1016/S1470-2045(09)70159-7 19556163

46. Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet. 2014;384:755–765. doi: 10.1016/S0140-6736(14)60892-8 25129328